Targeted cancer therapies are treatments that target specific characteristics within cancer cells while limiting harm to normal cells. They work by blocking the growth and spread of cancer cells. Common types of targeted therapies include monoclonal antibodies, tyrosine kinase inhibitors, angiogenesis inhibitors and apoptosis inducers. The global targeted cancer therapies market is estimated to be valued at US$ 1603.7 Mn in 2023 and is expected to exhibit a CAGR of 9 ... Read more
